Increased levels of fibrinogen, fibrin degradation products, D‐meter, VWF, and factor VIII were observed in COVID‐19 patients, which indicate the severity of the disease and thrombotic risk.55, 76, 77. This evidence concerns the gene VWF and COVID-19.